Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome

Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome

Topical ocular anaesthetic agents are frequently used for ophthalmic diagnosis and surgery. While corneal complications following long-term use or misuse of local anaesthetic solutions have been described, toxic epitheliopathy after a single application of six drops of preservative free oxybuprocain...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Case Reports 2013, Vol.2013
Hauptverfasser: Ansari, Humaira, Weinberg, Laurence, Spencer, Narelle
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title BMJ Case Reports
container_volume 2013
creator Ansari, Humaira
Weinberg, Laurence
Spencer, Narelle
description Topical ocular anaesthetic agents are frequently used for ophthalmic diagnosis and surgery. While corneal complications following long-term use or misuse of local anaesthetic solutions have been described, toxic epitheliopathy after a single application of six drops of preservative free oxybuprocaine is rare. In order to increase the awareness of this ocular complication, we report such a case in a patient with Sjogren's syndrome who presented for elective cataract surgery. We outline the mechanisms proposed to explain the ocular toxic effects of oxybuprocaine and discuss the management principles in preventing this complication in the context of Sjogren's syndrome.
doi_str_mv 10.1136/bcr-2013-010487
format Report
fullrecord <record><control><sourceid>istex</sourceid><recordid>TN_cdi_istex_primary_ark_67375_NVC_XMFPC7C7_W</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_NVC_XMFPC7C7_W</sourcerecordid><originalsourceid>FETCH-istex_primary_ark_67375_NVC_XMFPC7C7_W3</originalsourceid><addsrcrecordid>eNqVjcFKAzEURYMgWLRrt28j6iI1MdOmrgeLm4pg0e5COr5pX50mIYl1ZuG_m4U_4N1cLhzOZexSiomUana3aSK_F1JxIUU11ydsJPVUc_0g1mdsnNJelChZzSs1Yj8r31MDGCjvsCMfbN4N0EZ_AAuJ3LZDsCF01NhM3oFvIURMGI9lH7GQiOD7YfMVom8sOYQbMamuboFcMRQdocvwXfTwuvfbiO46QRrcR7nAC3ba2i7h-K_PGV88ruonTiljb0Kkg42DsfHTzLTSU_P8Vpv1cvFS61qbd_Vf_heR7Fuh</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Ansari, Humaira ; Weinberg, Laurence ; Spencer, Narelle</creator><creatorcontrib>Ansari, Humaira ; Weinberg, Laurence ; Spencer, Narelle</creatorcontrib><description>Topical ocular anaesthetic agents are frequently used for ophthalmic diagnosis and surgery. While corneal complications following long-term use or misuse of local anaesthetic solutions have been described, toxic epitheliopathy after a single application of six drops of preservative free oxybuprocaine is rare. In order to increase the awareness of this ocular complication, we report such a case in a patient with Sjogren's syndrome who presented for elective cataract surgery. We outline the mechanisms proposed to explain the ocular toxic effects of oxybuprocaine and discuss the management principles in preventing this complication in the context of Sjogren's syndrome.</description><identifier>EISSN: 1757-790X</identifier><identifier>DOI: 10.1136/bcr-2013-010487</identifier><language>eng</language><publisher>BMJ Publishing Group Ltd</publisher><ispartof>BMJ Case Reports, 2013, Vol.2013</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Ansari, Humaira</creatorcontrib><creatorcontrib>Weinberg, Laurence</creatorcontrib><creatorcontrib>Spencer, Narelle</creatorcontrib><title>Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome</title><title>BMJ Case Reports</title><addtitle>BMJ Case Reports</addtitle><description>Topical ocular anaesthetic agents are frequently used for ophthalmic diagnosis and surgery. While corneal complications following long-term use or misuse of local anaesthetic solutions have been described, toxic epitheliopathy after a single application of six drops of preservative free oxybuprocaine is rare. In order to increase the awareness of this ocular complication, we report such a case in a patient with Sjogren's syndrome who presented for elective cataract surgery. We outline the mechanisms proposed to explain the ocular toxic effects of oxybuprocaine and discuss the management principles in preventing this complication in the context of Sjogren's syndrome.</description><issn>1757-790X</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2013</creationdate><recordtype>report</recordtype><recordid>eNqVjcFKAzEURYMgWLRrt28j6iI1MdOmrgeLm4pg0e5COr5pX50mIYl1ZuG_m4U_4N1cLhzOZexSiomUana3aSK_F1JxIUU11ydsJPVUc_0g1mdsnNJelChZzSs1Yj8r31MDGCjvsCMfbN4N0EZ_AAuJ3LZDsCF01NhM3oFvIURMGI9lH7GQiOD7YfMVom8sOYQbMamuboFcMRQdocvwXfTwuvfbiO46QRrcR7nAC3ba2i7h-K_PGV88ruonTiljb0Kkg42DsfHTzLTSU_P8Vpv1cvFS61qbd_Vf_heR7Fuh</recordid><startdate>20130913</startdate><enddate>20130913</enddate><creator>Ansari, Humaira</creator><creator>Weinberg, Laurence</creator><creator>Spencer, Narelle</creator><general>BMJ Publishing Group Ltd</general><scope>BSCLL</scope></search><sort><creationdate>20130913</creationdate><title>Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome</title><author>Ansari, Humaira ; Weinberg, Laurence ; Spencer, Narelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-istex_primary_ark_67375_NVC_XMFPC7C7_W3</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ansari, Humaira</creatorcontrib><creatorcontrib>Weinberg, Laurence</creatorcontrib><creatorcontrib>Spencer, Narelle</creatorcontrib><collection>Istex</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ansari, Humaira</au><au>Weinberg, Laurence</au><au>Spencer, Narelle</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome</atitle><jtitle>BMJ Case Reports</jtitle><addtitle>BMJ Case Reports</addtitle><date>2013-09-13</date><risdate>2013</risdate><volume>2013</volume><eissn>1757-790X</eissn><abstract>Topical ocular anaesthetic agents are frequently used for ophthalmic diagnosis and surgery. While corneal complications following long-term use or misuse of local anaesthetic solutions have been described, toxic epitheliopathy after a single application of six drops of preservative free oxybuprocaine is rare. In order to increase the awareness of this ocular complication, we report such a case in a patient with Sjogren's syndrome who presented for elective cataract surgery. We outline the mechanisms proposed to explain the ocular toxic effects of oxybuprocaine and discuss the management principles in preventing this complication in the context of Sjogren's syndrome.</abstract><pub>BMJ Publishing Group Ltd</pub><doi>10.1136/bcr-2013-010487</doi></addata></record>
fulltext fulltext
identifier EISSN: 1757-790X
ispartof BMJ Case Reports, 2013, Vol.2013
issn 1757-790X
language eng
recordid cdi_istex_primary_ark_67375_NVC_XMFPC7C7_W
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A45%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Toxic%20epitheliopathy%20from%20a%20single%20application%20of%20preservative%20free%20oxybuprocaine%20(0.4%25)%20in%20a%20patient%20with%20Sjogren's%20syndrome&rft.jtitle=BMJ%20Case%20Reports&rft.au=Ansari,%20Humaira&rft.date=2013-09-13&rft.volume=2013&rft.eissn=1757-790X&rft_id=info:doi/10.1136/bcr-2013-010487&rft_dat=%3Cistex%3Eark_67375_NVC_XMFPC7C7_W%3C/istex%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true